Scientific Agenda


Conference Home

Scientific Agenda

Accommodations & Travel

Sponsorship


February 2- 5, 2017

 

Thursday February 2nd

 
7:00 p.m. - 9:00 p.m. Welcome Reception and Pre-Registration
 

 

Friday February 3rd

 

7:00 a.m. - 8:00 a.m.

Registration Open

8:00 a.m. - 8:05 a.m.

Good Morning & Welcome Address
Dr. Scott Ernst, Conference Chair

8:05 p.m. - 8:15 p.m. 

Address From Not-For-Profit
Save Your Skin Foundation

8:15 a.m. - 9:00 a.m. Evolution of Molecular Diagnostics in 2017
Dr. Boris Bastian
9:00 a.m. - 9:45 a.m.

Sequencing of Targeted & Immunotherapy
Dr. Keith Flaherty

9:45 a.m. - 10:30 a.m. Predictive/Prognostic Immunological Factors Confirmed and Potential
Dr. Antoni Ribas
10:30 a.m. - 10:45 a.m. Break, Exhibits + Poster Viewing
10:45 a.m. - 11:30 a.m.

Immune Check Point Inhibitors: What It Is and What Is to Come
Dr. Jason Luke

11:30 a.m. - 11:45 a.m. Lunch Buffet Open
11:45 a.m. - 12:45 p.m. Lunch Presentation:
Zeroing in on BRAF Targeted Therapy: What We Know, What We Need to Know, and What Does the Future Look Like?

Dr. Jason Luke, Dr. Marcus Butler, Dr. Tara Baetz & Dr. David Hogg
12:45 p.m. - 1:00 p.m. Travel Time to Workshop of  Choice
1:00 p.m. - 2:00 p.m. Workshop Sessions
  A: Multidisciplinary Approach to Advanced Basal Cell Carcinoma
Dr. Axel Hauschild & Dr. Scott Ernst
  B: Dermatological Toxicity from Targeted Agents and Immunotherapy for Melanoma
Dr. Milan Anadkat
2:00 p.m. - 2:15 p.m. Break, Exhibits & Poster Viewing
2:15 p.m. - 3:00 p.m. Evolving Role of Surgery in the Immunotherapy Era / Management of Complex Situations
Dr. Merrick Ross
3:00 p.m. - 3:45 p.m. Intralesional Therapy
Dr. Claire Temple-Oberle
3:45 p.m. - 4:30 p.m. Re-thinking Adjuvant Therapy
Dr. Axel Hauschild
 4:30 p.m. - 4:45 p.m. Dinner Buffet Open
 4:45 p.m. - 6:15 p.m. Case Conference
Hosted by Dr. Scott Ernst, Dr. Joël Claveau & expert panel
   

Saturday February 4th

 

12:00 p.m. - 12:15 p.m.

Lunch Buffet Opens

12:15 p.m. - 1:15 p.m.

Lunch Presentation:
Difficult-To-Treat Subtypes of Melanoma: What Role Does Immunotherapy Play?
Dr. Antoni Ribas, Dr. Keith Flaherty & Dr. Michael Smylie

1:00 p.m. - 1:15 p.m.

Break, Exhibits + Poster Viewing

1:15 p.m. - 2:00 p.m.

Merkel Cell Carcinoma Management Re-visited
Dr. Joël Claveau, Dr. Vernon Sondak & Dr. David Hogg

2:00 p.m. - 2:45 p.m.

CTLA-4 and PD-1 Inhibitor Combinations
Dr. Michael Postow

2:45 p.m. - 3:00 p.m.

Break, Exhibits + Poster Viewing

3:00 p.m. - 4:00 p.m.

Workshop Sessions

 

Workshop C: Pathology – Challenging Pediatric Melanocytic Lesions
Dr. Charlene Hunter, Dr. Carolyn Shiau, Dr. Martin Trotter & Dr. Greg McKinnon
 

Workshop D: Managing Immune Therapy Toxicity
Dr. Jeffrey Weber & Dr. David Hogg

4:00 p.m. - 4:15 p.m.

Break, Exhibits + Poster Viewing

4:15 p.m. - 5:15 p.m.

Optimal Surveillance Strategies Post Treatment: Both Low and High Risk Patients
Dr. Frances Wright, Dr. Teresa Petrella, Dr. Vernon Sondak, & Dr. Axel Hauschild

5:15 p.m. - 6:00 p.m.

Patient and Physician Input to Health Technology Assessments in 2017: Insights for Success
Barry Stein, President, Colorectal Cancer Association of Canada

6:00 p.m. - 6:30 p.m.

Upcoming Cell Therapy & Immunotherapy Trials: What's Being Conducted in Canada
Dr. Marcus Butler & Dr. Wilson Miller

 

 

 Sunday February 5th

 

6:30 a.m. - 7:00 a.m.

Breakfast Buffet Opens

7:00 a.m. - 8:00 a.m.

Breakfast Presentation:
Making the Right Choices for Patients: Combination Therapy in the Canadian Landscape
Dr. Axel Hauschild, Dr. Jeffrey Weber, Dr. Michael Smylie & Dr. Joël Claveau

8:00 a.m. - 8:05 a.m.

Good Morning Address
Dr. Scott Ernst, Conference Chair

8:05 a.m. - 9:00 a.m.

Abstract Presentations and Awards Ceremony
Hosted by Dr. Thomas Salopek

9:00 a.m. - 9:45 a.m.

Immune Therapy and Auto-Immune Disease
Dr. Jeffrey Weber

9:45 a.m. - 10:30 a.m.

Health Economics Surrounding Management of Melanoma in Canada
Dr. Nicole Mittmann, Dr. Nicole Look Hong, Dr. Stuart Peacock & Dr. Claire de Oliveira

10:30 a.m. - 10:45 a.m.

Closing Remarks & Thank You
Dr. Scott Ernst, Conference Chair